Table 2.
Log-Transformed PBF per ROI | With Zero-Lethality Attempters |
Without Zero-Lethality Attempters |
||||||
---|---|---|---|---|---|---|---|---|
Estimate | t Value | P Value | Adjustedb | Estimate | t Value | P Value | Adjustedb | |
RN | 0.08 | 2.88 | .01 | NA | 0.12 | 4.43 | .002 | NA |
Amygdala | 0.01 | 0.48 | .64 | 0.64 | 0.02 | 0.68 | .51 | 0.51 |
Hippocampus | 0.05 | 1.61 | .13 | 0.15 | 0.07 | 1.82 | .10 | 0.11 |
Parahippocampal gyrus | 0.05 | 1.65 | .12 | 0.15 | 0.07 | 2.13 | .06 | 0.08 |
Temporal lobe | 0.05 | 1.64 | .12 | 0.15 | 0.08 | 2.13 | .06 | 0.08 |
Anterior cingulate gyrus | 0.06 | 1.79 | .09 | 0.15 | 0.09 | 2.27 | .04 | 0.08 |
Dorsal PFC | 0.07 | 1.84 | .09 | 0.15 | 0.10 | 2.44 | .03 | 0.08 |
Medial PFC | 0.06 | 1.65 | .12 | 0.15 | 0.09 | 2.05 | .07 | 0.08 |
Orbital PFC | 0.05 | 1.56 | .14 | 0.15 | 0.09 | 2.13 | .06 | 0.08 |
Insula | 0.05 | 2.31 | .04 | 0.15 | 0.07 | 2.41 | .04 | 0.08 |
Occipital lobe | 0.05 | 1.71 | .11 | 0.15 | 0.09 | 2.17 | .05 | 0.08 |
Parietal lobe | 0.06 | 1.71 | .11 | 0.15 | 0.09 | 2.24 | .05 | 0.08 |
Abbreviations: BPF, binding potential; NA, not applicable in primary analysis; PFC, prefrontal cortex; RN, raphe nuclei; ROI, region of interest.
Patients underwent imaging with carbon 11-labeled 3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)-benzonitrile ([11C]DASB).
Significance levels for exploratory analyses are adjusted using the Benjamini-Hochberg method.